Latest research report on ‘Human Microbiome Market’ delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business.
Human Microbiome Market is valued at USD 210.3 Million in 2018 and expected to reach USD 744.6 Million by 2025 with the CAGR of 19.8% over the forecast period.
The leading market players mainly include:
Global human microbiome market report covers prominent players like Avidbiotics Inc., Avidbiotics Corp., 4D Pharma, Series Therapeutics, Second Genome, Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, BiomX Ltd., and others.
The detailed segments and sub-segment of the market are explained below:
By Product Type:
- Other Products
- Autoimmune Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Other Diseases
Get Full information of This Report@ https://brandessenceresearch.com/healthcare/human-microbiome-market-development